期刊文献+

心血宁片治疗瘀阻脑络证Ⅱ期高血压病临床试验研究 被引量:5

Clinical Research on Xinxuening Tablet for Hypertension with Ⅱ Stage of Blood Stasis in Brain Collaterals
下载PDF
导出
摘要 目的:观察心血宁片治疗瘀阻脑络证Ⅱ期高血压病临床疗效性和使用安全性。方法:采用随机、阳性药对照的方法,将临床试验病例120例随机分为试验组与对照组并平均分配给三家符合要求的医院,分别投以心血宁片和心可舒片4周,比较两组疗效差异。结果:心血宁片能够降低血压,对瘀阻脑络证有改善作用,对不同病情、不同性别、不同病程、不同病程年龄段高血压均有疗效,在疗程期内随着用药延长疗效明显增强。结论:心血宁片治疗瘀阻脑络证Ⅱ期高血压病安全有效,是一种安全、有效的纯中药降压药。 Objective : To observe the clinical efficacy and the safety of Xinxuening Tablet on treating hypertension with Ⅱ stage of blood stasis in brain collaterals. Methods: The randomized, positive drug control was used. 120 clinical cases were randomly divided into experimental group (Xinxuening) and control group (Xinxueshu), and average allocated to the three hospital which met the requirements. The difference between the two groups after four weeks was compared. Re- sults: Xinxuening can reduce blood pressure, relieve blood stasis in brain collaterals; had curative effect on hypertension of different conditions, different genders, different courses, different ages. In the treatment period, the efficacy had obvious enhancement with the medication. Conclusions: Xinxuening is safe and effective on treating hypertension with Ⅱstage of blood stasis in brain collaterals. It is a safe and effective medication of pure Chinese medicine.
出处 《中华中医药学刊》 CAS 2013年第4期764-766,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家科技人员服务企业资助项目(SQ2009GJB0002495) 辽宁省科技厅科学计划基金重大重点资助项目(2007226010) 辽宁省知识产权局专利技术转化基金资助项目(2006)
关键词 心血宁片 降低血压 Xinxuening reduce blood pressure
  • 相关文献

参考文献2

二级参考文献12

  • 1Takahashi Y,Nishida Y,Nakayama T,et al.Adverse effect profile of trichlormethiazide:a retrospective observational study[J].Cardiovasc Diabetol,2011,10(5):45.
  • 2Ohta Y,Tsuchihashi T,Onaka U,et al.Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients[J].Intern Med,2010,49(15):1483-1487.
  • 3Messerli FH,Makani H,Halpem D.Gout[J].N Engl J Med,2011,364(19):1876-1877.
  • 4Elisaf M,Tsimichodimos V,Bairaktari E,et al.Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia[J].J Cardiovasc Pharmacol,1999,34(1):60-63.
  • 5Shahinfar S,Simpson RL,Carides AD,et al.Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia[J].Kidney Int,1999,56(5):1879-1885.
  • 6Sato M,Iwanaga T,Mamada H,et al.Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin Ⅱ receptor blockers[J].Pharm Res,2008,25(3):639-646.
  • 7渠敬峰,李勇,郭宗杨,徐锋.老年高血压脑出血患者危险因素分析[J].齐齐哈尔医学院学报,2009,30(17):2124-2125. 被引量:3
  • 8尹纪红.老年高血压脑出血患者的临床护理分析[J].中国医药指南,2010,8(35):327-328. 被引量:4
  • 9冯江,孙祥冬.老年高血压脑出血手术治疗预后的影响因素分析[J].生物医学工程学进展,2010,31(4):220-222. 被引量:11
  • 10张凌云.老年高血压脑出血患者行微创血肿清除术的护理体会[J].中外医疗,2011,30(9):158-158. 被引量:10

共引文献9

同被引文献100

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部